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Summary Background and Aim: Hypersensitivity pneumonitis (HP) is an immunolo-
gically induced inflammation of the lung parenchyma, though bronchial airways may
be also involved. The aim of this study was to compare the cellular profiles of
induced sputum (IS) in patients with newly diagnosed HP to that of healthy subjects,
and to examine the relationship between inflammatory cells from IS and BAL.
Methods: Nine HP patients and 9 healthy volunteers were studied. IS was obtained
by inhalation of hypertonic saline solution in all subjects. Bronchoscopy was
performed on a different occasion in all patients and in five controls.
Results: IS was well tolerated and preferred to BAL by all subjects. Both IS and BAL
from HP patients showed a significant increase in total cells (Po0.02 and Po0.001)
and in lymphocytes (Po0.02 and Po0.001) and a significant decrease in
macrophages (Po0.05 and Po0.001), when compared with normal subjects. In HP
patients, total cells number in IS was higher than that in BAL (Po0.02). Moreover,
the percentage of lymphocytes was significantly lower in IS than in BAL (Po0.001).
No significant relationship was found between total cells or inflammatory cells from
IS and the corresponding ones from BAL and wide limits of agreement were found
between lymphocytes from IS and BAL.
Conclusions: This study demonstrated that both BAL and IS from newly diagnosed
HP patients contained significantly more total cells and lymphocytes, when
compared to healthy subjects. Moreover, differential cell counts in HP patients
showed that IS and BAL reflected different compartments of inflammation. Thus, IS
could represent a complementary, but not alternative tool to bronchoscopy both in
research and in the clinical monitoring of HP patients.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Hypersensitivity pneumonitis (HP), also known as
extrinsic allergic alveolitis, is an immunologically
induced inflammation of the lung parenchyma
resulting from repeated inhalations of a variety
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of causal agents, including organic dusts and
chemical agents. HP may occur in several clinical
forms and may lead to irreversible pulmonary
damage, depending on several factors, including
the amount and duration of exposure to the
antigen, the nature of causal agents, and the host
response.1
The disease is characterised by a diffuse and
predominantly mononuclear cell inflammation of
the small airways and pulmonary parenchyma2 and
the main pathophysiologic process of patients with
HP is a T lymphocytes alveolitis.3,4 The analysis of
cells recovered in bronchoalveolar lavage (BAL) has
been extensively used as diagnostic tool since it
reflects the inflammatory cell population of the
lung interstitium.5 In HP patients, BAL shows an
increased number of lymphocytes and the analysis
of T cell surface phenotypes revealed a strong
predominance of CD8þT lymphocytes.6,7 In HP
patients, the immune inflammatory process is
not compartmentalised within the alveolar walls,
but it can also involve the bronchial airways.
In these patients, the bronchial epithelium may
be extensively damaged during the active phase
of disease,8 the computed tomography can show
a variety of bronchial wall abnormalities9 and a
bronchial responsiveness to methacholine may be
found.10,11
During the past decade, induced sputum (IS) by
hypertonic saline has been widely used to assess
airway inflammation in asthma and chronic ob-
structive pulmonary disease,12 since it provides
reliable results, that are comparable to other
invasive technique, such as mucosal biopsy and
BAL. In fact, in asthmatics, eosinophil count of IS
was significantly related to that of BAL;13 moreover,
the percentage of CD4þ lymphocytes in IS has
been found to significantly correlate with that in
BAL.14 Recently, IS has been proposed in the
assessment of interstitial lung disease,15 since it
provided reliable results in pneumoconiosis,16
sarcoidosis,17,18 non-granulomatous interstitial lung
disease,19 pulmonary involvement in Crohn’s dis-
ease,20 and Fabry’s disease.21
Until now, the potential use of IS in the
assessment of pulmonary inflammation due to HP
has been poorly examined. Additionally, in HP
patients the cellular profile analysis of proximal
airway samples, such as IS, could add information
to that coming out from the assessment of more
distal samples of airways, such as BAL. Therefore,
the aim of this study was to compare the cellular
profiles of IS in patients with newly diagnosed HP to
that of healthy subjects, and to examine whether
or not inflammatory cell counts from IS are related
to those from BAL.
Methods
Subjects
We studied nine patients (two female, age range
30–70 years, all non-smokers) affected by HP.
Diagnosis was based on symptoms (cough and/or
exertional dyspnoea), standard chest X-ray, high-
resolution computed tomography (HRCT) and la-
boratory test results (serum antibody to Micropo-
lyspora Faeni in seven patients and serum antibody
to avian droppings in two patients). According to
HRCT patterns,22 eight patients had subacute HP
(four patients had patch ground glass opacity, three
had hazy small nodular opacities, and 1 had small
amount of fibrosis) and one patient had chronic HP
(fibrosis with traction bronchiectasis and variable
amount of honeycombimg). None of the patients
received oral or inhaled corticosteroids or anti-
biotics during the 4 months preceding the study.
The control group included nine healthy volun-
teers (six female, age range 21–40 years) recruited
among medical students and hospital staff. They
were lifetime non-smokers and did not experience
any acute respiratory illness in the 4 weeks prior to
the study. Each subject gave informed consent to
the study protocol.
Lung function test
Pulmonary function was measured by a flow-sensing
spirometer connected to a computer for data
analysis (Vmax 22, Sensor Medics, Yorba Linda,
US). Forced vital capacity (FVC), forced expiratory
volume at the 1st second (FEV1), and forced mid-
expiratory flow (FEF2575) were recorded. Carbon
monoxide transfer coefficient (KCO) was also mea-
sured by the single breath method. All these
variables are expressed as percent of predicted
value.23,24
Induced sputum and processing
Sputum was induced by the inhalation of hypertonic
saline as previously described.12,17 All subjects
inhaled 3% hypertonic saline solution four times
for 5min using an ultrasonic nebulizer (Heyer Orion
1, BAD EMS; mean volume output: 2.40ml/min).
Throughout the procedure, subjects were encour-
aged to cough and to expectorate into a plastic
container. Three flow volume curves were per-
formed before and after each inhalation and the
best FEV1 was recorded. Induction of sputum was
stopped if FEV1 value fell by at least 15% from
baseline or if troublesome symptoms occurred.
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The volume of the sputum sample was measured
and an equal volume of dithiotreitol 0.1% was
added and incubated at 371C for 30min. Ten
microlitres of the homogenised sample were used
to determine the total cell count and results were
expressed as number of cells  105/ml. The
remaining sputum was washed with phosphate-
buffered saline and centrifuged at 2000 rpm for a 5-
min period. The supernatant was aspirated, and
cell pellets were re-suspended in saline (2000 rpm
for 10min), cytocentrifuged at 600 rpm for 10min
and stained with May-Grnwald-Giemsa. The sample
was considered adequate if the squamous cells
percentage was less than 20%. The percentage of
macrophages, neutrophils, lymphocytes, eosino-
phils and epithelial cells were counted by two of
the authors (R. D. and S. M.) on at least 400 cells,
excluding squamous cells.
Bronchoscopy and BAL processing
At least 2 days after IS, subjects underwent
bronchoscopy by flexible fibreoptic bronchoscope
(Olympus 1T10; Tokyo Japan). Subjects were
treated with atropine (0.5mg intramuscularly).
Then local anaesthesia was performed by inhalation
of an aerosol solution of 22ml of 2% lidocaine
followed by the sucking of a 20-mg tablet of
tetracaine 15-min before bronchoscopy. BAL was
carried out as previously described.17 The broncho-
scope was wedged into a segment of the right
middle lobe, and three 50-ml aliquots of sterile
saline solution, warmed at 371C, were instilled into
the subsegmental bronchus. Fluid was gently
aspirated immediately after each aliquot was
introduced and collected in a sterile container.
During the bronchoscopy, oxygen saturation and
ECG tracing were continuously monitored.
An aliquot was reserved for total cell number
using a Nageotte’s chamber and results were
expressed as cells  105/ml. The remaining fluid
was immediately centrifuged at 800 rpm for 10min
at 41C. The cell pellet was washed twice with
phosphate-buffered saline solution (without Ca2þ
and Mg2þ ). Cytocentrifugates were stained by the
May-Grnwald-Giemsa method. The differential cell
count of macrophages, neutrophils, lymphocytes,
eosinophils and epithelial cells was made under
light microscope (magnification  1000) by count-
ing at least 400 cells. Two of the authors (R.D. and
S.M.) independently performed differential cell
counts without any knowledge of subjects char-
acteristics. Bronchoscopy was performed in all
patients with HP and in five out of nine normal
subjects.
Statistical analysis
Data were tested for normal distribution by the
Kolmogorov test and expressed as means 7SD.
Differences between cell counts in IS and BAL from
patients with HP and from normal subjects were
analysed by unpaired Student’s t-test. Differences
between total and differential cell counts from IS
and BAL in patients with HP were evaluated paired
Student’s t-test. Correlations between different
cells from different samples were examined by
Pearson’s correlation coefficient. The agreement
between IS and BAL from HP patients was assessed
by the method of differences against the means
according to Bland and Altman.25 Probability values
of Po0.05 were accepted as significant.
Results
Characteristics of subjects are reported in Table 1.
Patients with HP were significantly older (Po0.01)
and had lower values of FVC (Po0.02), FEV1
(Po0.001), FEF2575 (Po0.001), when compared
to normal controls. Moreover, all patients had KCO
values less than 80% of predicted value (Table 1).
All subjects well tolerated both IS and broncho-
scopy procedure, without experiencing any adverse
events. The sputum samples were adequate in
all cases.
The results of total and differential cell counts in
IS and BAL from patients with HP and normal
subjects are reported in Table 2. With respect to IS
samples, HP patients had a significant increase in
total cells (81 105/ml749 vs. 34.4 105/ml721,
Po0.02) and in lymphocytes (473% vs. 0.872%,
Po0.02), and a significant decrease in macro-
phages (57731% vs. 81712%, Po0.05), when
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Table 1 Subjects’ characteristics.
HP Normal subjects
No. 9 9
Sex (M/F) 7/2 3/6
Age (years) 53715** 3076
FVC (% pred) 91717* 114712
FEV1 (% pred) 90713
** 117711
FEF2575 (% pred) 72716
** 108720
KCO (% pred) 6679 F
Values are expressed as mean7SD. M¼male; F¼ female;
FVC¼ forced vital capacity; FEV1¼ forced expiratory
volume 1st second; FEF2575¼ forced mid-expiratory
flow; KCO¼ carbon monoxide transfer coefficient.
*Po0.05; **Po0.01.
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compared with normal subjects (Fig. 1). Similarly,
in BAL samples HP patients had a significant
increase in total cells (38.5 105/ml 7 9.9 vs.
14.4 105/ml736, Po0.001) and in lymphocytes
(57725% vs. 373%, Po0.001), and a significant
decrease in macrophages (35721% vs. 9573%,
Po0.001), when compared to those of normal
subjects (Table 2).
In HP patients, the number of total cells
recovered in IS was higher than that in BAL samples
(Po0.02). Moreover, the percentage of lympho-
cytes was significantly lower in IS than in BAL
(Po0.001) (Fig. 2). The percentages of eosinophils
and neutrophils were numerically, but not statisti-
cally, increased in HP patients, when compared to
those of controls (Table 2).
No significant relationship was found between
total cells or percentage of any other inflammatory
cell from IS and the corresponding ones from BAL.
Moreover, wide limits of agreement were found
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Table 2 Cell counts from samples of induced sputum and BAL in HP patients and normal subjects.
Cell type IS BAL
HP patients
(n¼ 9)
Normal subjects
(n¼ 9)
HP patients
(n¼ 9)
Normal subjects
(n¼ 5)
Total cells (no. 105/ml) 81749*# 34.4721 38.579.9** 14.4736
Macrophages (%) 57731* 81712 35721** 9573
Neutrophils (%) 32735 15711 578 271
Lymphocytes (%) 473*w 0.872 57725** 373
Eosinophils (%) 478 0.270.2 375 0.270.3
Epithelial cells (%) 374 472 0.870.5 0.470.2
Values are expressed as mean7SD.
*Po0.05 vs. IS of normal subjects; #Po0.05 vs. BAL of HP patients; wPo0.001 vs. BAL of HP patients; **Po0.01 vs. BAL of normal
subjects.
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Figure 1 Total cells (upper panel) and lymphocytes
(lower panel) counts in IS from nine patients with newly
diagnosed hypersensitivity pneumonitis (open circle) and
from nine healthy subjects (closed circle).
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Figure 2 Total cells (upper panel) and lymphocytes
(lower panel) counts in IS (open circle) and in BAL (closed
circle) from nine patients with newly diagnosed hyper-
sensitivity pneumonitis.
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between lymphocytes from IS and BAL. The bias
between lymphocytes in IS and lymphocytes in BAL
was 53% and the limits of agreement ranged from
–5% to –101% (Fig. 3).
Discussion
The results of this study demonstrated that not only
BAL samples but also IS samples from newly
diagnosed untreated patients with HP contained
significantly more total cells and lymphocytes,
when compared to those recovered in healthy
subjects. As expected, lymphocytes counts in BAL
samples from HP patients were higher than those in
IS samples. Moreover, differential cell counts in the
two different samples from HP patients showed a
lack of correlation and thus suggest that IS and BAL
reflected different compartments of inflammation.
Finally, IS was well tolerated and preferred to BAL
by all subjects.
Several factors are known to remarkably influ-
ence the diagnostic accuracy of differential cell
count from BAL samples.3,4 Nevertheless, the
assessment of lymphocytes count and CD4/
CD8 ratio in BAL samples is still in use and
recommended in the clinical evaluation of HP
patients.26,27 The percentage of lymphocytes in
BAL from our patients with newly diagnosed HP is
comparable to that previously reported in several
studies,4,28 ranging between 1.7% and 82%.
We found that the number of lymphocytes from IS
in patients with HP was increased, as compared to
that from healthy subjects. An increased number of
lymphocytes in IS is of interest, since sputum
samples are much more concentrated in cells than
BAL. Surprisingly, the potential use of IS samples in
these patients has received very little attention. As
far as we know, IS as investigative tool in HP
patients has been used only by Mroz and co-
workers.29 In their recent report, the authors found
a higher lymphocyte count in IS from HP and
sarcoidosis patients, as compared to that from
COPD patients.29 A control group of healthy
subjects was not considered.29 Moreover, they
demonstrated that the number of lymphocytes in
IS from patients with HP is sufficiently high to
identify CD4þ and CD8þ lymphocytes and assess
the expression of their surface markers of activa-
tion. Interestingly, recent studies have demon-
strated that indeed, this was also possible in
asthmatics who showed rather low percentages of
sputum lymphocytes,30 as well as in patients with
sarcoidosis18,19 and with COPD.31 Whether this non-
invasive and better tolerated procedure could be
also useful in the assessment of disease activity in
HP, especially in advanced forms and in the follow-
up, is probably worth studying.
It is of interest that an increased percentage of
lymphocytes was present in IS from most untreated
patients with HP, as compared to that of healthy
controls. However, unlike BAL, IS lymphocyte
percentage could not discriminate clearly between
HP patients and healthy controls, because of a
broad overlap. Indeed, IS primarily samples the
more proximal airways, whereas BAL mainly sam-
ples the alveolar component.12 Although the
dynamics of lymphocytes in the lung has not yet
been fully established,32 they could accumulate by
active recruitment and selection, by local accumu-
lation or as the consequence of decreased apopto-
sis. It is noteworthy that in patients with HP,
lymphocytes from BAL showed an increased moti-
lity33 and an upregulation of alpha E beta 7 integrin
expression that contributes to their selective
accumulation.34 They may undergo an oligoclonal
expansion,35 and show a prolonged survival due to
decreased apoptosis.36 The effect of microenviron-
ment on sputum lymphocyte in HP patients is not
known, but it is tempting to hypothesise that the
bronchial as well as the alveolar compartment
could contribute to their increased count. Inter-
estingly, lymphocytes are the most frequent cells in
bronchial biopsy from asthmatic patients, but very
few are recovered in IS or BAL.14
In conclusion, we demonstrated that cell counts
in IS from patients with newly diagnosed HP do not
reflect the inflammatory process of the alveolar
compartment. However, the cell concentration and
the percentage of recovered lymphocytes in spu-
tum are higher than in healthy controls, though
with considerable overlap. Thus, we would suggest
that this inexpensive, non-invasive, and easily
ARTICLE IN PRESS
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Figure 3 Plot of the difference between the percentage
of lymphocytes in IS and in BAL against the mean of IS and
BAL in nine patients with HP. The bias (continuous line)
and limits of agreement (interrupted lines) were –53%
and –5% to –101%, respectively.
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repeatable method could represent a complemen-
tary, but not alternative tool to bronchoscopy both
in research and in the clinical monitoring of
patients with hypersensitivity pneumonitis.
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